[Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].

[1]  D. Dreßler.  Apomorphin bei der Behandlung des Morbus Parkinson , 2005, Der Nervenarzt.

[2]  S. Ho,et al.  Prophylacticiv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[3]  S. Factor,et al.  A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events. , 2001, Archives of neurology.

[4]  G K Wenning,et al.  Apomorphine: An underutilized therapy for Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[5]  P. Odin,et al.  Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up , 1998, Journal of neurology, neurosurgery, and psychiatry.

[6]  A. Hughes,et al.  Apomorphine‐induced penile erections in Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[7]  E. Tolosa,et al.  Long-term treatment with intermitent intranasal or subcutaneous apormorphine in patients with levodopa-related motor fluctuations. , 1997, Clinical neuropharmacology.

[8]  P. Leigh,et al.  Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. , 1997, Parkinsonism & related disorders.

[9]  O. Lindvall,et al.  Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[10]  P. Pollak,et al.  Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery , 1992, The Lancet.

[11]  A. Lees,et al.  Subcutaneous apomorphine in the treatment of Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[12]  A. Benabid,et al.  Subcutaneous apomorphine in Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[13]  O.H.G. Wilder-3nith.  Drug induced movement disorders , 2012 .

[14]  A. Hughes,et al.  Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years , 1993, Movement disorders : official journal of the Movement Disorder Society.